Literature DB >> 28335948

Re: Wells et al.: Aflibercept, Bevacizumab, or Ranibizumab for diabetic macular edema: two year results from a comparative effectiveness randomized clinical trial (Ophthalmology. 2016;123:1351-1359).

Pradeep Venkatesh1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28335948     DOI: 10.1016/j.ophtha.2016.08.034

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  1 in total

1.  Evaluation of ranibizumab and aflibercept for the treatment of diabetic macular edema in daily clinical practice.

Authors:  Pablo Plaza-Ramos; Enrique Borque; Alfredo García-Layana
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.